Sandbox:Rahmah Al-Edresi: Difference between revisions
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 9: | Line 9: | ||
==[[Xyz overview|Overview]]== | ==[[Xyz overview|Overview]]== | ||
==[[ historical perspective|Historical Perspective]]== | ==[[Xyz historical perspective|Historical Perspective]]== | ||
==[[Xyz classification|Classification]]== | ==[[Xyz classification|Classification]]== | ||
Latest revision as of 17:21, 4 December 2020
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sandbox:Rahmah Al-Edresi On the Web |
|
American Roentgen Ray Society Images of Sandbox:Rahmah Al-Edresi |
|
Risk calculators and risk factors for Sandbox:Rahmah Al-Edresi |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rahmah Al-Edresi, M.D.[2]
Synonyms and keywords:Idiopathic thrombocytopenic purpura, Immune thrombocytopenic purpura, Autoimmune thrombocytopenic purpura.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies